查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2112263

生物製藥第三方物流市場規模、佔有率和趨勢分析報告：按供應鏈、服務類型、地區和細分市場預測（2026-2033 年）

Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain Logistics, Non-cold Chain Logistics), By Service Type (Transportation, Warehousing & Storage), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

生物製藥第三方物流市場概述

全球生物製藥第三方物流(3PL) 市場預計到 2025 年將達到 1,520 億美元，從 2026 年的 1,614 億美元成長到 2033 年的 2,584 億美元，2026 年至 2033 年的複合年成長率為 6.9%。

北美市場處於領先地位，預計到 2025 年將佔據最大佔有率，達到 41.7%。生物製藥第三方物流(3PL) 產業正經歷強勁成長，這得益於生物製藥和生物類似藥商業化的不斷擴大、對溫控和符合 GDP 標準的物流基礎設施的需求不斷成長、製藥和生物技術公司對供應鏈運營外包的日益成長、臨床試驗和先進療法（包括細胞和基因療法）的擴展，以及對用於實現端到端產品的監管

全球生物製藥分銷日益複雜，加上對溫度敏感產品的嚴格處理要求以及跨境藥品貿易的擴張，促使製造商與專業的第三方物流(3PL) 供應商合作，這些供應商提供包括運輸、倉儲、包裝、庫存管理和低溫運輸能力在內的綜合服務。

生物製藥、生物相似藥和先進療法的快速發展仍然是市場成長的主要驅動力之一。與傳統藥品不同，生物製藥需要特殊的運輸、溫控儲存、經過驗證的包裝以及貫穿整個供應鏈的持續監控，以維持產品療效並確保符合監管要求。隨著單株抗體、疫苗、重組蛋白以及細胞和基因療法的商業化進程不斷推進，對擁有符合GDP認證的基礎設施和全球分銷網路的專業物流供應商的需求也顯著成長。

此外，醫藥供應鏈營運外包的日益普及是推動市場成長的另一個主要因素。製藥和生物技術公司越來越依賴專業的第三方物流供應商，以最佳化分銷效率、提高合規性、降低營運成本並增強全球市場的供應鏈韌性。管理高度監管的生物製藥供應鏈需要低溫運輸管理、海關程序、序列化、庫存管理和最後一公里配送方面的專業知識，因此外包成為一種經濟高效且擴充性的解決方案。物流業的策略投資和收購進一步推動了這一趨勢。例如，2025年3月，DHL宣布收購專業醫藥物流供應商CryoPDP，以進一步擴展其綜合醫療保健物流組合和專業低溫運輸網路，增強其在臨床試驗物流、生物製藥分銷以及細胞和基因療法運輸方面的能力。

然而，溫控基礎設施所需的大量資本投資、嚴格的全球監管合規要求以及跨國際市場運輸高度敏感生物製藥的複雜營運流程，都限制市場成長。儘管如此，先進療法的商業化進程、生物製藥產品線的拓展、數位化供應鏈技術的日益普及以及對符合GDP標準的低溫運輸基礎設施的持續投資，預計將為生物製藥領域的第三方物流（3PL）供應商創造重要的長期商機。隨著製藥企業擴大將複雜的物流營運外包給能夠提供安全、規範且全球一體化供應鏈解決方案的專業合作夥伴，預計該市場將保持穩定成長。

目錄

第1章 研究方法和範圍

第2章執行摘要

第3章：生物製藥第三方物流市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 科技情勢
  • 定價模式分析
  • 關稅影響分析
  • 市場分析工具

第4章：生物製藥第三方物流市場：供應鏈估算與趨勢分析

  • 生物製藥第三方物流市場：供應鏈趨勢分析
  • 生物製藥第三方物流市場估算與預測：依供應鏈分類，2021-2033年
  • 低溫運輸物流
  • 非低溫運輸物流

第5章：生物製藥第三方物流市場：按服務類型分類的估算與趨勢分析

  • 生物製藥第三方物流市場：按服務類型分類的趨勢分析
  • 生物製藥第三方物流市場：按服務類型分類的估算與預測，2021-2033年
  • 運輸
    • 空運貨物
    • 海上運輸
    • 陸路交通
  • 倉庫/存儲
  • 其他服務

第6章：生物製藥第三方物流市場：區域估算與趨勢分析

  • 區域市場概覽
  • 2025年及2033年區域市佔率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • UAE
    • 沙烏地阿拉伯
    • 科威特
    • 卡達
    • 阿曼

第7章 競爭情勢

  • 主要公司分類
    • Market Leaders
    • Emerging Players
  • 2025年市佔率及估值分析（熱圖分析）
  • 公司簡介
    • DHL International GmbH
    • SF Express
    • FedEx
    • United Parcel Service of America, Inc.
    • Cencora, Inc.
    • DB Schenker
    • Kuehne and Nagel
    • Kerry Logistics Network Limited
    • Agility Public Warehousing Company KSCP
Product Code: GVR-2-68038-773-5

Biopharmaceutical Third-Party Logistics Market Summary

The global biopharmaceutical third-party logistics market size was valued at USD 152.0 billion in 2025 and is projected to grow from USD 161.4 billion in 2026 to USD 258.4 billion by 2033, at a CAGR of 6.9% from 2026 to 2033. North America dominated the market, accounting for the largest share of 41.7% in 2025. The biopharmaceutical third-party logistics (3PL) industry is experiencing robust growth, driven by the expanding commercialization of biologics and biosimilars, increasing demand for temperature-controlled and GDP-compliant logistics infrastructure, rising outsourcing of supply chain operations by pharmaceutical and biotechnology companies, growth in clinical trials and advanced therapies including cell and gene therapies, and continuous investments in digital supply chain technologies for end-to-end product visibility and regulatory compliance.

The increasing complexity of global biopharmaceutical distribution, combined with stringent handling requirements for temperature-sensitive products and growing cross-border pharmaceutical trade, is encouraging manufacturers to partner with specialized third-party logistics providers offering integrated transportation, warehousing, packaging, inventory management, and cold chain capabilities.

The rapid expansion of biologics, biosimilars, and advanced therapies remains one of the primary factors driving market growth. Unlike conventional pharmaceuticals, biologics require specialized transportation, temperature-controlled storage, validated packaging, and continuous monitoring throughout the supply chain to preserve product efficacy and regulatory compliance. The growing commercialization of monoclonal antibodies, vaccines, recombinant proteins, and cell and gene therapies has significantly increased the demand for specialized logistics providers with GDP-certified infrastructure and global distribution networks.

Furthermore, increasing outsourcing of pharmaceutical supply chain operations is another major driver supporting market expansion. Pharmaceutical and biotechnology companies are increasingly relying on specialized third-party logistics providers to optimize distribution efficiency, improve regulatory compliance, reduce operational costs, and enhance supply chain resilience across global markets. Managing highly regulated biopharmaceutical supply chains requires specialized expertise in cold chain management, customs clearance, serialization, inventory control, and last-mile delivery, making outsourcing a cost-effective and scalable solution. Strategic investments and acquisitions across the logistics industry further demonstrate this trend. For instance, in March 2025, DHL announced the acquisition of specialty pharmaceutical logistics provider CryoPDP to strengthen its capabilities in clinical trial logistics, biopharma distribution, and cell and gene therapy transportation, further expanding its integrated healthcare logistics portfolio and specialized cold chain network.

However, the market growth is constrained by the high capital investment required for temperature-controlled infrastructure, stringent global regulatory compliance requirements, and the operational complexity associated with transporting highly sensitive biopharmaceutical products across international markets. Nevertheless, increasing commercialization of advanced therapies, expanding biologics pipelines, growing adoption of digital supply chain technologies, and continued investments in GDP-compliant cold chain infrastructure are expected to create substantial long-term opportunities for biopharmaceutical third-party logistics providers. The market is expected to maintain steady growth as pharmaceutical manufacturers increasingly outsource complex logistics operations to specialized partners capable of delivering secure, compliant, and globally integrated supply chain solutions.

Global Biopharmaceutical Third-party Logistics Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global biopharmaceutical third-party logistics market report based on supply chain, service type, and region:

  • Supply Chain Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Cold Chain Logistics
  • Non-cold Chain Logistics
  • Service Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Transportation
    • Air Freight
    • Sea Freight
    • Overland
  • Warehousing and Storage
  • Other Services
  • Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Supply Chain
    • 1.2.2. Service Type
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Bottom-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biopharmaceutical Third-Party Logistics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancements in Logistics
      • 3.2.1.2. Growing Applications of Reverse Logistics in the Biopharmaceutical Industry
      • 3.2.1.3. Rising Demand for Cold Chain Logistics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Compliance Issues While Outsourcing
      • 3.2.2.2. Stringent Regulatory Framework
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. Biopharmaceutical Third-Party Logistics Market: Supply Chain Estimates & Trend Analysis

  • 4.1. Biopharmaceutical Third-Party Logistics Market, By Supply Chain: Segment Dashboard
  • 4.2. Biopharmaceutical Third-Party Logistics Market, By Supply Chain: Movement Analysis
  • 4.3. Biopharmaceutical Third-Party Logistics Market Estimates & Forecasts, By Supply Chain, 2021 - 2033 (USD Million/Billion)
  • 4.4. Cold Chain Logistics
    • 4.4.1. Cold Chain Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 4.5. Non-cold Chain Logistics
    • 4.5.1. Non-cold Chain Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 5. Biopharmaceutical Third-Party Logistics Market: Service Type Estimates & Trend Analysis

  • 5.1. Biopharmaceutical Third-Party Logistics Market, By Service Type: Segment Dashboard
  • 5.2. Biopharmaceutical Third-Party Logistics Market, By Service Type: Movement Analysis
  • 5.3. Biopharmaceutical Third-Party Logistics Market Estimates & Forecasts, By Service Type, 2021 - 2033 (USD Million/Billion)
  • 5.4. Transportation
    • 5.4.1. Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 5.4.2. Air Freight
      • 5.4.2.1. Air Freight Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 5.4.3. Sea Freight
      • 5.4.3.1. Sea Freight Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 5.4.4. Overland
      • 5.4.4.1. Overland Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 5.5. Warehousing and Storage
    • 5.5.1. Warehousing and Storage Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 5.6. Other Services
    • 5.6.1. Other Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 6. Biopharmaceutical Third-Party Logistics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2025 & 2033
  • 6.3. North America
    • 6.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.3.2. U.S.
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.4. Europe
    • 6.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Framework
      • 6.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Framework
      • 6.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.5.5. Australia
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.5.6. Thailand
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.5.7. South Korea
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.6. Latin America
    • 6.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.7. MEA
    • 6.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.7.3. UAE
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.7.4. Saudi Arabia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.7.6. Qatar
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory Framework
      • 6.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
    • 6.7.7. Oman
      • 6.7.7.1. Key Country Dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory Framework
      • 6.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 7. Competitive Landscape

  • 7.1. Key Participant Categorization
    • 7.1.1. Market Leaders
    • 7.1.2. Emerging Players
  • 7.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
  • 7.3. Company Profiles
    • 7.3.1. DHL International GmbH
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Service Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. SF Express
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Service Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. FedEx
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Service Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. United Parcel Service of America, Inc.
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Service Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Cencora, Inc.
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Service Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. DB Schenker
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Service Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Kuehne and Nagel
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Service Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Kerry Logistics Network Limited
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Service Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Agility Public Warehousing Company K.S.C.P.
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Service Benchmarking
      • 7.3.9.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million/Billion)
  • Table 4. Global Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 5. Global Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 6. North America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 7. North America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 8. North America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 9. U.S. Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 10. U.S. Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 11. Canada Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 12. Canada Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 13. Mexico Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 14. Mexico Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 15. Europe Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 16. Europe Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 17. Europe Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 18. UK Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 19. UK Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 20. Germany Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 21. Germany Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 22. France Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 23. France Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 24. Italy Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 25. Italy Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 26. Spain Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 27. Spain Biopharmaceutical Third-Party LogisticsMarket Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 28. Denmark Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 29. Denmark Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 30. Sweden Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 31. Sweden Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 32. Norway Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 33. Norway Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 34. Asia Pacific Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 35. Asia Pacific Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 36. Asia Pacific Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 37. Japan Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 38. Japan Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 39. China Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 40. China Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 41. India Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 42. India Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 43. Thailand Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 44. Thailand Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 45. South Korea Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 46. South Korea Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 47. Australia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 48. Australia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 49. Latin America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 50. Latin America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 51. Latin America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 52. Brazil Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 53. Brazil Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 54. Argentina Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 55. Argentina Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 56. Middle East & Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
  • Table 57. Middle East & Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 58. Middle East & Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 59. South Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 60. South Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 61. Saudi Arabia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 62. Saudi Arabia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 63. UAE Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 64. UAE Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 65. Kuwait Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 66. Kuwait Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 67. Oman Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 68. Oman Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)
  • Table 69. Qatar Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Supply Chain, 2021 - 2033 (USD Million/Billion)
  • Table 70. Qatar Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million/Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2025 (USD Billion)
  • Fig. 16 Biopharmaceutical Third-Party Logistics Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Biopharmaceutical Third-Party Logistics Market: Supply Chain outlook and key takeaways (USD Million/Billion)
  • Fig. 20 Biopharmaceutical Third-Party Logistics Market: Supply Chain movement analysis
  • Fig. 21 Cold Chain Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 22 Non-cold Chain Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 23 Biopharmaceutical Third-Party Logistics Market: Service Type outlook and key takeaways (USD Million/Billion)
  • Fig. 24 Biopharmaceutical Third-Party Logistics Market: Service Type movement analysis
  • Fig. 25 Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 26 Air Freight Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 27 Sea Freight Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 28 Overland Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 29 Warehousing and Storage Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 30 Other Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 31 Regional Marketplace: Key Takeaways
  • Fig. 32 North America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 33 U.S. Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 34 Canada Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 35 Mexico Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 36 Europe Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 37 UK Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 38 Germany Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 39 France Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 40 Italy Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 41 Spain Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 42 Sweden Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 43 Denmark Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 44 Norway Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 45 Asia Pacific Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 46 Japan Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 47 China Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 48 India Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 49 Thailand Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 50 South Korea Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 51 Australia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 52 Latin America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 53 Brazil Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 54 Argentina Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 55 Middle East & Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 56 South Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 57 Saudi Arabia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 58 UAE Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 59 Kuwait Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 60 Oman Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • Fig. 61 Qatar Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)